| The evolution of poxvirus vaccines L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez, J García-Arriaza, ... Viruses 7 (4), 1726-1803, 2015 | 221 | 2015 |
| SEVA 3.0: an update of the Standard European Vector Architecture for enabling portability of genetic constructs among diverse bacterial hosts E Martínez-García, A Goni-Moreno, B Bartley, J McLaughlin, ... Nucleic acids research 48 (D1), D1164-D1170, 2020 | 178 | 2020 |
| Distinct immunogenicity and efficacy of poxvirus-based vaccine candidates against Ebola virus expressing GP and VP40 proteins A Lázaro-Frías, S Gómez-Medina, L Sánchez-Sampedro, K Ljungberg, ... Journal of virology 92 (11), 10.1128/jvi. 00363-18, 2018 | 50 | 2018 |
| High Quality Long-Term CD4+ and CD8+ Effector Memory Populations Stimulated by DNA-LACK/MVA-LACK Regimen in Leishmania major BALB/c Model of … L Sanchez-Sampedro, CE Gómez, E Mejias-Perez, CO S. Sorzano, ... PloS one 7 (6), e38859, 2012 | 38 | 2012 |
| Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140 (ZM96) and Gag (ZM96)-Pol-Nef (CN54 … B Perdiguero, CE Gómez, V Cepeda, L Sánchez-Sampedro, ... Journal of virology 89 (2), 970-988, 2015 | 34 | 2015 |
| SEVA 4.0: an update of the Standard European Vector Architecture database for advanced analysis and programming of bacterial phenotypes E Martínez-García, S Fraile, E Algar, T Aparicio, E Velázquez, B Calles, ... Nucleic Acids Research 51 (D1), D1558-D1567, 2023 | 33 | 2023 |
| Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination … L Fernández, E Carrillo, L Sánchez-Sampedro, C Sánchez, ... Frontiers in Immunology 9, 843, 2018 | 18 | 2018 |
| Modification of promoter spacer length in vaccinia virus as a strategy to control the antigen expression M Di Pilato, L Sanchez-Sampedro, E Mejías-Pérez, COS Sorzano, ... Journal of General Virology 96 (8), 2360-2371, 2015 | 18 | 2015 |
| Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens L Sánchez-Sampedro, CE Gómez, E Mejías-Pérez, E Pérez-Jiménez, ... Journal of Virology 87 (12), 6955-6974, 2013 | 18 | 2013 |
| The evolution of poxvirus vaccines. Viruses 7: 1726–1803 L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez, J García-Arriaza, ... Article CAS PubMed PubMed Central, 2015 | 14 | 2015 |
| Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein A Vijayan, CE Gómez, DA Espinosa, AG Goodman, L Sanchez-Sampedro, ... The Journal of Immunology 188 (12), 6407-6417, 2012 | 12 | 2012 |
| NYVAC vector modified by C7L viral gene insertion improves T cell immune responses and effectiveness against leishmaniasis L Sanchez-Sampedro, E Mejias-Perez, CÓS Sorzano, JL Najera, ... Virus research 220, 1-11, 2016 | 4 | 2016 |
| Bivalent NYVAC-based Vaccine Candidates against HIV/AIDS Expressing Clade C Trimeric Soluble gp140 (ZM96) and Gag (ZM96)-Pol-Nef (CN54) as VLPs B Perdiguero, CE Gómez, MV Cepeda, L Sánchez-Sampedro, ... AIDS Research and Human Retroviruses 30 (S1), A119-A119, 2014 | | 2014 |
| Mutantes replicativos y atenuados del virus vaccinia como candidatos vacunales frente a la leishmaniasis L Sánchez Sampedro | | 2012 |
| Sonicando L Sánchez-Sampedro CSIC-Centro Nacional de Biotecnología (CNB), 2008 | | 2008 |
